Jessica Schneider

5PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 05, 2026
Glofitamab crosses the blood-brain barrier and exhibits activity against primary and secondary CNS lymphoma.

Marie Anne-Catherine Neumann, Jessica Schneider, Max Szameitat

|Feb 09, 2026
MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Jan-Michel Heger, Julia Mattlener, Helen Kaul

|Sep 30, 2024
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma.

Jan-Michel Heger, Laman Mammadova, Julia Mattlener

|Nov 10, 2023
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.

Jan-Michel Heger, Julia Mattlener, Jessica Schneider

Pageof 1